|
Volumn 22, Issue 4, 2014, Pages 165-167
|
Overcoming the current deadlock in antibiotic research
|
Author keywords
Antibiotic resistance; Public health; Public private partnership (PPP)
|
Indexed keywords
ANTIBIOTIC AGENT;
CORALLOPYRONIN A;
CYTOFAB;
GSK 1322322;
MEDI 4893;
MONOCLONAL ANTIBODY;
PEPTIDE DEFORMYLASE INHIBITOR;
RNA DIRECTED RNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
CLINICAL RESEARCH;
DEVELOPING COUNTRY;
DRUG INDUSTRY;
FILARIASIS;
FINANCIAL MANAGEMENT;
HIGH THROUGHPUT SCREENING;
MALARIA;
NOTE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
PUBLIC-PRIVATE PARTNERSHIP;
STAPHYLOCOCCUS AUREUS;
TUBERCULOSIS;
VALIDATION PROCESS;
ANTIBIOTIC RESISTANCE;
PUBLIC HEALTH;
PUBLIC-PRIVATE PARTNERSHIP (PPP);
ANTI-BACTERIAL AGENTS;
BACTERIAL INFECTIONS;
CAPITAL FINANCING;
DRUG DISCOVERY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
PUBLIC-PRIVATE SECTOR PARTNERSHIPS;
|
EID: 84897039080
PISSN: 0966842X
EISSN: 18784380
Source Type: Journal
DOI: 10.1016/j.tim.2013.12.007 Document Type: Note |
Times cited : (111)
|
References (8)
|